Prevalence of Inflammatory Bowel Disease in Patients With Perianal Disease

Bikkur Holim Hospital

Status: Completed

Conditions: Inflammatory Bowel Disease; Perianal Fistula; Perianal Abscess

Treatments: Device: capsule endoscopy

Study type: Interventional

Funder types: Other

Identifiers

NCT00972088

Peri Anal Study

Details and patient eligibility

About

To show that prevalence of inflammation of the small bowel in patients with anorectal disease is under-diagnosed based on colonoscopy ileoscopy alone.

Full description

IBD of the small bowel is associated with perianal disease such as ano-rectal abscesses and fistulas. Colonoscopy with ileoscopy and small bowel series are relied upon to document the presence of Crohn's disease of the small bowel. We suspect that the prevalence of inflammatory small bowel disease is underestimated.

In my practice I have cases that had negative colonoscopy ileoscopy and positive findings at capsule endoscopy. These patients are receiving therapy for Crohn's disease. It is important to prove that the prevalence is higher.

Capsule Endoscopy (CE) is the "first line tool" diagnostic procedure for the examination of the small bowel. It is performed today in more than 2,900 GI clinics in hospitals, outpatient departments and physicians' offices all over the world using the PillCam® Platform. Over 500,000 CE procedures with the Given PillCam SB have been completed to date.

Enrollment: 26 patients

Sex: All

Ages: 10 to 80 years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• Patients between the ages of 10 - 80

• Patients with anorectal abscess of anorectal fistula

• Patient is male or female

• Within three months prior to enrollment, patient has normal test results for at least one of the following tests:

  1. Colonoscopy with Ileoscopy, and/or
  2. Colonoscopy with small bowel series, and/or
  3. Colonoscopy with CT enterography

• Within three months prior to enrollment patient has the following lab tests: Blood count, sedimentation rate, CRP. IBD serology is optional.

• Sign informed consent

Exclusion criteria

• Can not sign informed consent
• Contraindications to colonoscopy ileoscopy or capsule endoscopy
• History of established IBD

Trial design

Primary purpose: Diagnostic

Allocation: N/A

Interventional model: Single Group Assignment

Masking: None (Open label)

---

26 participants in 1 patient group

capsule endoscopy

Other group

Description:

patients eligible according to inclusion criteria who underwent a capsule endoscopy

Treatment:

Device: capsule endoscopy